MEDTECHVISION 2019

What is the current state of the precision health landscape? Hear from a key opinion leader within this evolving space as she shares a brief history of the achievements, failures and continued promise of precision health.

Speakers:
Bray Patrick-Lake, Director, Strategic Partnerships, Evidation Health

In recent years, the expanded availability of consumer wearables, sensors, and digital health platforms have flooded healthcare with vast amounts of patient data. Our panel of experts will explore how some companies are effectively gathering enormous volumes of input and tackling the difficult task of contextualizing and extracting salient information to develop more precise solutions that are safe and potentially more effective for patients.

Speakers:
Rowan Chapman, Independent Board Member and Advisor
Amy Friel, VP Marketing, Tidepool

Moderator:
Deb Kilpatrick, CEO, Evidation Health

Andrea Downing
Community Data Organizer
Co-Founder, The Light Collective

From the FDA to MedTech and Pharma, collaboration amongst government and industry is driving new approaches, awareness and adoption of precision medicine. We will highlight some of the recent successes and discuss continued challenges, from new regulatory approaches to market access and commercialization.

Speakers:
Sang’ona Oriedo, Sr. Director of Marketing Communications, iRhythm Technologies
Olivia Ware, Sr. Vice President, Proteus Digital Health
Rebecca Messing Haigler, Value, Market Access & Health Economics Lead, Verily

Moderator:
Brittany Wright Schuck, PhD, Scientific Reviewer, FDA

Speaker: Giulia C. Kennedy, PhD, Chief Scientific and Medical Officer, Veracyte, Inc.

Moderator:
Nada Hanafi, Chief Strategy Officer, Experien Group, LLC

With an increased ability to focus on the attributes of individual patients, targeted therapies are more likely to be efficacious, less likely to lead to adverse side effects, and, in many circumstances, more cost-effective for both patients and payers. We will explore two precision medicine case studies to reveal lessons learned while launching these data-rich solutions, and share inventive approaches that other organizations may elect to utilize in adapting, growing, and providing enhanced value to patients by incorporating elements of precision medicine.

Speakers:
Chi Nguyen, Vice President, Marketing, NeuroPace
Martha Morrell, M.D., Chief Medical Officer, NeuroPace
Andreana Dereniak, Global Strategic Marketing, Head of Business Development & Strategic Alliances, Abbott Diabetes Care
Lynne Lyons, Senior Scientific Affairs Manager, Abbott Diabetes Care

Moderator:
Liz Cumby, CEO, Cumby Consulting Medical Education Experts